Shorter chemo shows promise for kids with hodgkin lymphoma

NCT ID NCT00846742

First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 19 times

Summary

This study tested a shorter course of chemotherapy (Stanford V) in 88 children and young adults with favorable Hodgkin lymphoma. Those who still had signs of cancer after chemo also received low-dose radiation to the affected area. The goal was to see if this approach could improve the number of patients whose cancer completely disappears, while reducing long-term side effects. Results help doctors find the right balance of treatment intensity for this group.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Hospital of Illinois at OSF St. Francis Medical Center

    Peoria, Illinois, 61637, United States

  • Dana-Farber Harvard Cancer Center

    Boston, Massachusetts, 02115, United States

  • Maine Children's Cancer Program (MCCP)

    Scarborough, Maine, 04074, United States

  • Packard Children's Hospital, Stanford University

    Palo Alto, California, 94304, United States

  • Rady Children's Hospital- San Diego

    San Diego, California, 92123, United States

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

Conditions

Explore the condition pages connected to this study.